Study Evaluating AWBAT-D Versus the Standard of Care of Split-thickness Skin Graft Donor Sites

NCT01252836 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2016-12-15

No results posted yet for this study

Summary

Use of AWBAT-D on split thickness skin graft sites will reduce healing time and pain level.

Conditions

  • Healing of Donor Site
  • Pain Level

Interventions

DEVICE

AWBAT-D

Application of AWBAT-D bioengineered device

Sponsors & Collaborators

  • Georgetown University

    lead OTHER

Principal Investigators

  • Christopher A Attinger, MD · Georgetown University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01252836 on ClinicalTrials.gov